Ram Sagar

Ram Sagar


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 December 2016 in Nature
Verified
Journal Article
Closed access
CGCara A. Griffiths
Cara A. Griffiths
RSRam Sagar
Ram Sagar
YGYiqun Geng
Yiqun Geng
LPLucia F. Primavesi
Lucia F. Primavesi
MPMitul K. Patel
Mitul K. Patel
BDBenjamin G. Davis
Benjamin G. Davis

1 February 2013 in Plant Physiology and Biochemistry
Verified
Journal Article
Closed access
CNCatia Nunes
Catia Nunes
LPLucia F. Primavesi
Lucia F. Primavesi
MPMitul K. Patel
Mitul K. Patel
EMEleazar Martinez-Barajas
Eleazar Martinez-Barajas
SPStephen J. Powers
Stephen J. Powers
Matthew PaulMatthew Paul
Matthew Paul

18 February 2013 in Chemical Reviews
Verified
Journal Article
Closed access
LRL. Vijaya Raghava Reddy
L. Vijaya Raghava Reddy
VKVikas Kumar
Vikas Kumar
RSRam Sagar
Ram Sagar
ASArun K. Shaw
Arun K. Shaw

7 November 2023 in RSC Advances
Verified
Journal Article
Open access
PDF file
GTGhanshyam Tiwari
Ghanshyam Tiwari
AKAshish Khanna
Ashish Khanna
VMVinay Kumar Mishra
Vinay Kumar Mishra
RSRam Sagar
Ram Sagar
This review highlights recent developments in the microwave-assisted organic synthesis of N- and O-containing heterocycles with specific examples of pyrazolopyrimidines-, coumarin-, quinoline-, and isatin-based scaffolds and their associated biological activities.

20 April 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
PKPriti Kumari
Priti Kumari
VMVishnu S. Mishra
Vishnu S. Mishra
CNChintam Narayana
Chintam Narayana
AKAshish Khanna
Ashish Khanna
ACAnindita Chakrabarty
Anindita Chakrabarty
RSRam Sagar
Ram Sagar
C-glycosides are important class of molecules exhibit diverse biological activities and present as structural motif in many natural products. Two series of new pyrazoline and isoxazole bridged indoleC-glycoside molecular hybrids (n = 36) were efficiently synthesized starting from diverse indole 3-carboxaldehydes derived α, β-unsaturated ketone derivatives of β-D-glucosyl-propan-2-one, β-D-galactosyl-propan-2-one and β-D-mannosyl-propan-2-one, reacting with hydrazine hydrate and hydroxyl amine hydrochloride in shorter reaction time (15 min) under microwave assisted condition. Anticancer activity of these newly synthesized pyrazoline and isoxazole bridged indolesC-glycoside hybrids were determined in details through cellular assays against MCF-7, MDA-MB-453 and MDA-MB-231 cancer cell lines. The selected library members displayed low micromolar (IC50 = 0.67–4.67 µM) and selective toxicity against breast cancer cell line (MCF-7). Whereas these compounds were nontoxic towards normal cell line (MCF-10A). Mechanistic studies showed that, active compounds inhibit COX-2 enzyme, which was also supported by molecular docking studies. These findings are expected to provide new leads towards anticancer drug discovery.

19 July 2023 in RSC Advances
Verified
Journal Article
Open access
PDF file
RYRakhi Yadav
Rakhi Yadav
DMDilkhush Meena
Dilkhush Meena
KSKavita Singh
Kavita Singh
RTRajdeep Tyagi
Rajdeep Tyagi
YYYogesh Yadav
Yogesh Yadav
RSRam Sagar
Ram Sagar
This review highlights the recent synthetic developments of benzothiazole based anti-tubercular compounds and their in vitro and in vivo activity. The inhibitory concentrations of the newly synthesized molecules were compared with the standard reference drugs. The better inhibition potency was found in new benzothiazole derivatives against M. tuberculosis. Synthesis of benzothiazole derivatives was achieved through various synthetic pathways including diazo-coupling, Knoevenagel condensation, Biginelli reaction, molecular hybridization techniques, microwave irradiation, one-pot multicomponent reactions etc. Other than recent synthetic developments, mechanism of resistance of anti-TB drugs is also incorporated in this review. Structure activity relationships of the new benzothiazole derivatives along with the molecular docking studies of selected compounds have been discussed against the target DprE1 in search of a potent inhibitor with enhanced anti-tubercular activity.